[DISCLOSURE] PanGen (222110) announced on Oct. 14 that it has acquired a European patent regarding expression vector for animal cells.

The firm already holds patents in the US, Japan, China and South Korea, and has patents pending in Brazil, Malaysia and India.

By Park Yuna (yunapark@heraldcorp.com)